Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2008
11/06/2008CA2685106A1 6-phenylpyrimidinones as pim modulators
11/06/2008CA2683866A1 Bridged six-membered ring compounds
11/06/2008CA2682508A1 Dual-acting antihypertensive agents
11/05/2008EP1988078A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
11/05/2008EP1987831A1 Compounds effecting glucokinase
11/05/2008EP1987819A1 Injectable presentation type of flupirtin
11/05/2008EP1987717A1 Pyridon carboxamides, agents containing these but not impacting useful plants and method for their manufacture and application
11/05/2008EP1987030A1 3 -deazapurine derivatives as tlr7 modulators
11/05/2008EP1987005A2 New pyridin-3-amine derivatives
11/05/2008EP1987004A2 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
11/05/2008EP1987003A1 Pyridine-2-carboxamide derivatives
11/05/2008EP1987002A1 Pyridin-4 -ylmethylamides for combating pests
11/05/2008EP1986982A2 Dehydrogenation process
11/05/2008EP1638980B1 Process for preparing 3-aminothienopyridone derivatives
11/05/2008EP1567499B1 Substituted pyridyloxyalkylamides and their use as fungicides
11/05/2008EP1534276B1 Non-nucleoside reverse transcriptase inhibitors
11/05/2008EP1309544B1 Compounds acting as melanocortin receptor ligands
11/05/2008EP1053227B1 Ppar-gamma modulators
11/05/2008CN101300241A Piperazine derivatives as antimalarial agents
11/05/2008CN101300234A Compounds and compositions for protein kinase inhbitors
11/05/2008CN101300231A Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents
11/05/2008CN101298436A Fluorinating agent and method for producing fluorine-containing compound using the same
11/05/2008CN101298427A Diaryl urea compound and use thereof
11/05/2008CN100430411C Activators for oligonucleotide synthesis
11/05/2008CN100430405C Processes for preparing calcium salt forms of statins
11/05/2008CN100430381C Method for preparing 3,5,6-trichloro pyridine-2-sodium alcoholate without solvent
11/05/2008CN100430380C Pyridylacetylenes for use as radiotracers and imaging agents
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/04/2008US7446222 2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-carboxylic acid; neuropathic pain; chronic articular pain (e.g. rheumatoid arthritis, osteoarthritis, rheumatoid spondylitis, gouty arthritis and juvenile arthritis) including the property of disease modification and joint structure preservation
11/04/2008US7446210 Factor Xa compounds
11/04/2008US7446206 N-((2Z)-2-((4-hydroxyphenyl) amino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide crystalline form 2
11/04/2008US7446129 Suitable benzylation chemistry is to extract a hydrogen from a PDE4 inhibitor, preferably with a base, then react resulting nucleophilic PDE4 inhibitor with benzylating agent, e.g., benzyl bromide; no emetogenic side effects
11/04/2008US7446117 Cox-2 inhibiting pyridine derivatives
11/04/2008US7446115 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide
11/04/2008US7446109 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
11/04/2008US7446104 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
10/2008
10/30/2008WO2008130508A1 Indanone derivatives that inhibit prolyl hydroxylase
10/30/2008WO2008130312A1 A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701
10/30/2008WO2008129129A1 Heterocyclic phenyl carbamates as novel faah-inhibitors
10/30/2008WO2008128744A1 Method for the hydrolysis of heteroaromatic nitriles in aqueous fluids
10/30/2008WO2008128622A2 Pyridine compounds for liquid-crystalline mixtures
10/30/2008WO2008106692B1 Pim kinase inhibitors and methods of their use
10/30/2008WO2008022204A3 Thiourea compounds
10/30/2008US20080269496 Catalytic system of asymmetric reactions in aqueous media; react a silicon enolate and formaldehyde; catalyst obtained by mixing chiral ligands with scandium triflate
10/30/2008US20080269470 Dianionic chelating ligands with a bridged-bis-bi-aryl structure; For catalytic polymerization of ethylene/olefin copolymers
10/30/2008US20080269296 Diaryl ethers as opioid receptor antagonists
10/30/2008US20080269292 N-deacetylthiocolchicine deriatives, their use and pharmaceutical formulations containing them
10/30/2008US20080269265 Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
10/30/2008US20080269262 Therameutin Modulators
10/30/2008US20080269255 Hypotensive agents; atherosclerosis; congestive heart failure; hypertrophy; cardiomyopathy; diabetic nephropathy; restenosis; cognition activator; Alzheimer's disease; anxiolytic agents
10/30/2008US20080269237 Histone deacetylase inhibitor; anticancer agents; antiproliferative agents; antitumor agents; psoriasis; piperazine compound containing a carbamic acid group
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
10/30/2008US20080269216 Gastrointestinal disorders; irritable bowel syndrome
10/30/2008US20080269215 Bisamide Inhibitors of Hedgehog Signaling
10/30/2008US20080269059 Pyridinecarboxamides, useful-plant-protecting composition comprising them and processes for their prepartion and their use
10/30/2008US20080263785 Hair affinity; light and shampooing fastness; such as 1-(6-{3-[4-(1H-imidazol-1-yl)butyl]-1H-imidazol-3-ium-1-yl}hexyl)-4-{[methyl(phenyl)hydrazono]methyl}quinolinium dibromide; multicompartment cosmetic kits
10/30/2008DE102008017025A1 Pyridin-Verbingungen für flüssigkristalline Mischungen Pyridine-Verbingungen for liquid crystalline mixtures
10/30/2008CA2685141A1 New compounds 806
10/30/2008CA2684347A1 A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701
10/30/2008CA2680356A1 Method for the hydrolysis of heteroaromatic nitriles in aqueous fluids
10/29/2008EP1985669A1 Photosensitizer dye
10/29/2008EP1985614A1 Improved method for producing nitroguanidine derivative
10/29/2008EP1984340A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives
10/29/2008EP1984339A1 Pyridine derivatives as sodium channel modulators
10/29/2008EP1984338A2 Pyridylphenyl compounds for inflammation and immune-related uses
10/29/2008EP1984337A2 Vinyl-phenyl derivatives for inflammation and immune-related uses
10/29/2008EP1984322A1 Benzamide and heteroarene derivatives
10/29/2008EP1828134B1 Piperazinyl pyridine derivatives as anti-obesity agents
10/29/2008EP1687284B1 p-38 KINASE INHIBITORS
10/29/2008EP1664016B1 Therapeutic agents useful for treating pain
10/29/2008EP1641758B1 Diphenylpyridine derivatives, preparation and therapeutic application thereof
10/29/2008EP1216228B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
10/29/2008CN201139962Y Stuffing column for pure pyridine production
10/29/2008CN101296913A Heterocyclic amide derivatives useful as microbiocides
10/29/2008CN101296908A Tricyclo substituted amides as glucokinase modulators
10/29/2008CN101296904A Amide derivatives as kinase inhibitors
10/29/2008CN101296901A HIV-1 protease inhibitors, and methods of making and using them
10/29/2008CN101296897A PPAR modulating biaromatic compounds
10/29/2008CN101296892A PPAR active compounds
10/29/2008CN101293900A Electrolytes for electrooptic devices comprising ionic liquids
10/29/2008CN101293868A Process for synthesizing D-alpha-(6-methyl-4-hydroxyl nicotinamide base)p-hydroxyphenylacetic acid
10/29/2008CN101293867A Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
10/29/2008CN101293866A Monophenol and bisphenol monomer containing pyridine group and preparation method thereof
10/29/2008CN101293799A Method for preparing aldehyde or ketone compounds with catalytic oxidation of alcohol compounds
10/29/2008CN100429203C Dyeing compsn. for kerationous fibres comprising particular dicationic diazo dye
10/28/2008USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent
10/28/2008US7442839 e.g. 4-{(1R)-2-[(6-{4-[3-(Cyclopentylsulfinyl)phenyl]butoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; beta 2-adrenoreceptor agonist; asthma, chronic obstructive pulmanory disease, bronchitis; antidepressant
10/28/2008US7442797 Platinum complex and light emitting device
10/28/2008US7442796 oxo-acids such as [3-(2,6-Dimethylbenzyloxy)-phenyl]-oxoacetic acid, used for treating insulin resistance, diabetes, hyperlipemia, liver disorders, cachexia, obesity, atherosclerosis and arteriosclerosis
10/28/2008US7442714 3-ethyl-5-methyl-2-(2-aminoethoxy-methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridine dicarboxylate gentisate; crystalline acid salt; low toxicity, excellent stability, improved pharmaceutical efficacies and long-lasting concentration in blood; cardiovascular diseases, hypotensive agent
10/28/2008US7442704 Amide derivatives
10/28/2008US7442702 Prostaglandin agonists
10/28/2008US7442698 Substituted heterocyclic compounds and methods of use
10/28/2008US7442689 Cardioprotective phosphonates and malonates
10/28/2008US7442475 rod-shaped molecular structure; polymerisable; high polarity and high positive values of dielectric anisotropy
10/28/2008US7442448 Phenyl pyridine-iridium metal complex compounds for organic electroluminescent device and organic electroluminescent device using thereof
10/28/2008CA2300319C 4-cyano-4-deformylsordaricin derivatives
10/23/2008WO2008127728A1 Biaryl compositions and methods for modulating a kinase cascade
10/23/2008WO2008127727A1 Biaryl compositions and methods for modulating a kinase cascade
1 ... 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 ... 633